The effectiveness of pyrazolo[3,4-d] pyrimidines against transplantable mouse tumors
- 1 September 1960
- Vol. 13 (5) , 959-966
- https://doi.org/10.1002/1097-0142(196009/10)13:5<959::aid-cncr2820130515>3.0.co;2-x
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Studies with the experimental antitumor agent 4-aminopyrazolo[3,4-d]pyrimidineCancer, 1960
- RELATIVE SENSITIVITY OF THE SOLID and ASCITES FORMS OF SARCOMA 180 and EHRLICH CARCINOMA TO INHIBITORY COMPOUNDS*Annals of the New York Academy of Sciences, 1958
- Potential Purine Antagonists. VI. Synthesis of 1-Alkyl- and 1-Aryl-4-substituted Pyrazolo[3,4-d]pyrimidines1,2The Journal of Organic Chemistry, 1956
- Potential Purine Antagonists. I. Synthesis of Some 4,6-Substituted Pyrazolo [3,4-d] pyrimidines1Journal of the American Chemical Society, 1956
- Inhibition of Experimental Neoplasms by 4-Aminopyrazolo(3,4-d)Pyrimidine.Experimental Biology and Medicine, 1955
- RESPONSE OF ACUTE LYMPHOCYTIC LEUKEMIAS TO THE PURINE ANTAGONIST 6‐MERCAPTOPURINEAnnals of the New York Academy of Sciences, 1954
- Observations on the Effect of a Folic-Acid Antagonist on Transplantable Lymphoid Leukemias in Mice2JNCI Journal of the National Cancer Institute, 1949
- Purine Metabolism in Tetrahymena and Its Relation to Malignant Cells in MiceScience, 1949
- A Quantitative Study of the Growth of the Walker Rat Tumor and the Flexner-Jobling Rat CarcinomaThe American Journal of Cancer, 1935